Merck Pre-Tax Income 2012-2026 | MRK

Merck pre-tax income for the twelve months ending March 31, 2026 was $11.630B, a 42.34% decline year-over-year.

  • Merck annual pre-tax income for 2025 was $21.067B, a 5.67% increase from 2024.
  • Merck annual pre-tax income for 2024 was $19.936B, a 955.37% increase from 2023.
  • Merck annual pre-tax income for 2023 was $1.889B, a 88.51% decline from 2022.

Merck Pre-Tax Income 2012-2026 | MRK

  • Merck annual pre-tax income for 2025 was $21.067B, a 5.67% increase from 2024.
  • Merck annual pre-tax income for 2024 was $19.936B, a 955.37% increase from 2023.
  • Merck annual pre-tax income for 2023 was $1.889B, a 88.51% decline from 2022.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B